HK$18.50
0.96% yesterday
Hong Kong, Oct 06, 10:08 am CET
ISIN
CNE100000FN7
Symbol
1099
Index

Sinopharm Group Stock price

HK$18.50
-0.18 0.96% 1M
+1.38 8.06% 6M
-2.80 13.15% YTD
-5.05 21.44% 1Y
+3.08 19.97% 3Y
+1.78 10.65% 5Y
-10.45 36.10% 10Y
-0.06 0.32% 20Y
Hong Kong, Closing price Mon, Oct 06 2025
-0.18 0.96%
ISIN
CNE100000FN7
Symbol
1099
Index

Key metrics

Basic
Market capitalization
HK$58.3b
Enterprise Value
HK$123.5b
Net debt
HK$65.2b
Cash
HK$38.5b
Shares outstanding
3.1b
Valuation (TTM | estimate)
P/E
7.7 | 6.9
P/S
0.1 | 0.1
EV/Sales
0.2 | 0.2
EV/FCF
-
P/B
0.7
Dividends
DPS
HK$0.74
Yield 1Y | 5Y
4.0% | 4.3%
Growth 1Y | 5Y
-22.7% | 2.5%
Payout 1Y | 3Y
29.9% | 30.1%
Increased
0 Years
Financials (TTM | estimate)
Revenue
HK$629.5b | HK$661.8b
EBITDA
- | HK$22.5b
EBIT
HK$20.2b | HK$19.3b
Net Income
HK$7.4b | HK$8.4b
Free Cash Flow
-
Growth (TTM | estimate)
Revenue
-2.5% | 3.6%
EBITDA
- | 5.1%
EBIT
-11.4% | -0.8%
Net Income
-21.3% | 9.0%
Free Cash Flow
-
Margin (TTM | estimate)
Gross
7.4%
EBITDA
- | 3.4%
EBIT
3.2%
Net
1.2% | 1.3%
Free Cash Flow
-
Financial Health
Equity Ratio
20.1%
Return on Equity
8.9%
ROCE
13.1%
ROIC
6.0%
Debt/Equity
1.2
More
EPS
HK$2.4
FCF per Share
-
Short interest
-
Employees
108k
Rev per Employee
HK$5.9m
Show more

Is Sinopharm Group a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,001 stocks worldwide.

Sinopharm Group Stock Analysis

Unlock Scores for Free

Analyst Opinions

22 Analysts have issued a Sinopharm Group forecast:

15x Buy
68%
6x Hold
27%
1x Sell
5%

Analyst Opinions

22 Analysts have issued a Sinopharm Group forecast:

Buy
68%
Hold
27%
Sell
5%

Financial data from Sinopharm Group

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
629,477 629,477
2% 2%
100%
- Direct Costs 582,843 582,843
2% 2%
93%
46,634 46,634
10% 10%
7%
- Selling and Administrative Expenses 27,064 27,064
8% 8%
4%
- Research and Development Expense - -
-
-
- -
-
-
- Depreciation and Amortization - -
-
-
EBIT (Operating Income) EBIT 20,181 20,181
11% 11%
3%
Net Profit 7,446 7,446
21% 21%
1%

In millions HKD.

Don't miss a Thing! We will send you all news about Sinopharm Group directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Sinopharm Group Co., Ltd. is a distributor of pharmaceutical and healthcare products and a value added supply chain service provider in the People's Republic of China. It operates through the following business segments: Pharmaceutical Distribution, Medical Devices, Retail Pharmacy, and Other Business. The Pharmaceutical Distribution segment provides distribution, logistics and other value-added services for domestic and international pharmaceutical and healthcare products manufacturers and other suppliers. The Medical Devices segment consists of the distribution of medical devices in China. The Retail Pharmacy segment refers to the network of retail drug stores in major cities of China via direct operations and franchises. The Other Business segment comprises of the production and sale of pharmaceutical products, chemical reagents and laboratory supplies. The company was founded on January 8, 2003 and is headquartered in Shanghai, China.

Head office China
Employees 108,217
Founded 2003
Website www.sinopharmgroup.com.cn

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today